Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Maxted

Sports Medicine Oklahoma City, OK Medical Doctor

NPI 1528329208 CMS profile 1232260

921 Ne 13Th St, Oklahoma City, OK 73104

Open in the dashboard

General payments

$22,891

138 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Maxted of Oklahoma City, OK is reported in the CMS Open Payments database as having received $22,891 across 138 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 71st percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,330 21
2024 General $183 4
2023 General $509 8
2022 General $4,139 34
2021 General $5,176 32
2020 General $4,021 16
2019 General $7,533 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Maxted
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Michael Maxted were reported at $1,330. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Michael Maxted Sports Medicine median Middle half National median
2019 $7,533 $1,176 $199–$4,249 $163
2020 $4,021 $708 $96–$2,890 $114
2021 $5,176 $1,213 $152–$3,994 $132
2022 $4,139 $1,230 $159–$3,998 $149
2023 $509 $584 $146–$2,836 $160
2024 $183 $628 $163–$3,168 $164
2025 $1,330 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Pylant Medical $15,782 27 payments
  2. Arthrex, Inc. $3,436 34 payments
  3. Stryker Corporation $2,338 59 payments
  4. Zimmer Biomet Holdings, Inc. $1,191 14 payments
  5. Smith+Nephew, Inc. $98 3 payments
  6. DePuy Synthes Sales Inc. $45 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $16,344 14 payments
  2. Food and Beverage $4,127 111 payments
  3. Travel and Lodging $2,420 13 payments
Products named General payments · program years 2019–2025
  1. ACCOLADE Hips $991 26 payments
  2. Avenir $812 9 payments
  3. ACCOLADE Hips $682 22 payments
  4. INSPACE $295 2 payments
  5. Persona $230 4 payments
  6. MAKO Knees, Hips $154 5 payments
  7. GPS III PLATELET CONCENTRATION SYSTEM $150 1 payment
  8. MAKO Knees, Hips $128 1 payment
  9. mymobility Platform Knees $80 3 payments
  10. mymobility Platform Hips $80 3 payments
  11. Other $353 11 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

138 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Oklahoma

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record